AboutRebisLab.
Built on Decades of Expertise
RebisLab R&D GmbH was founded in 2022 in Munich as a contract research organization serving biotech and pharmaceutical companies. Built on over 30 years of combined expertise in synthetic and medicinal chemistry, we bring the precision and dedication of academic research to commercial drug development.
We assist our clients with route scouting, contract research and synthesis, scale-up, and formulation development - treating each project individually and delivering tailored, cost-effective solutions from basic research through preclinical development.
Dr. Wael Saeb
CEO & Founder
Dr. Wael Saeb brings more than 30 years of experience in medicinal and synthetic chemistry across the biotech and pharmaceutical sectors. His expertise spans drug discovery, process chemistry, and pharmaceutical formulation, supported by numerous scientific publications and patents.
What we stand for.
Mission
Precise chemistry and pharmaceutical development for biotech and pharma - efficient, transparent, reliable.
Vision
A leading specialist laboratory for demanding drug substance and formulation development in Europe.
Values
Scientific precision, integrity, reproducibility.
What matters to us.
Your IP, Always Yours
Client intellectual property remains fully owned by the client. We do not develop competing products.
Tailored Solutions
We investigate medical-chemical parameters for each project individually - no one-size-fits-all approach.
Transparent Execution
Regular client communication throughout every project, from kick-off to final report.
- Start Your Project -
Ready to Advance Your Research?
Tell us about your project. We'll define the right approach and deliver tailored, cost-effective solutions.
Get in Touch→